摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-N-BOC-2-氨基-3-苯丙氰 | 172695-25-9

中文名称
(S)-N-BOC-2-氨基-3-苯丙氰
中文别名
(S)-N-逆丁氧羰基-2-氨基-3-苯丙氰
英文名称
tert-butyl (S)-(1-cyano-3-phenylpropan-2-yl)carbamate
英文别名
(S)-tert-Butyl (1-cyano-3-phenylpropan-2-yl)carbamate;tert-butyl N-[(2S)-1-cyano-3-phenylpropan-2-yl]carbamate
(S)-N-BOC-2-氨基-3-苯丙氰化学式
CAS
172695-25-9
化学式
C15H20N2O2
mdl
——
分子量
260.336
InChiKey
BEJMQXQXIQDKCZ-CYBMUJFWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    120-125 °C
  • 沸点:
    432.2±45.0 °C(Predicted)
  • 密度:
    1.067±0.06 g/cm3(Predicted)
  • 稳定性/保质期:

    遵照规定使用和储存,则不会分解。

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    19
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.47
  • 拓扑面积:
    62.1
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 安全说明:
    S36,S37
  • 危险类别码:
    R20/21/22
  • 海关编码:
    2926909090
  • 储存条件:
    存放于阴凉干燥处。

SDS

SDS:04ea082e5fdf8ee2271f7ef74ba3f6f7
查看
Name: (s)-n-boc-2-amino-3-phenylpropyl cyanide Material Safety Data Sheet
Synonym: (S)-N-tert-Butoxycarbonyl-2-amino-3-phenylpropyl cyanide
CAS: 172695-25-9
Section 1 - Chemical Product MSDS Name: (s)-n-boc-2-amino-3-phenylpropyl cyanide Material Safety Data Sheet
Synonym: (S)-N-tert-Butoxycarbonyl-2-amino-3-phenylpropyl cyanide
SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
172695-25-9 (S)-N-BOC-2-Amino-3-phenylpropyl cyani unlisted
Hazard Symbols: XN
Risk Phrases: 20/21/22
SECTION 3 - HAZARDS IDENTIFICATION EMERGENCY OVERVIEW Harmful by inhalation, in contact with skin and if swallowed. Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. May cause respiratory tract irritation.
Chronic:
Not available.
SECTION 4 - FIRST AID MEASURES
Eyes:
Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:


SECTION 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.
SECTION 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.
SECTION 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low. Exposure Limits CAS# 172695-25-9: Personal Protective Equipment
Eyes:
Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.
SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical State: Solid
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 120 - 125 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: >250 deg C
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C15H20N2O2
Molecular Weight: 260.34
SECTION 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported
SECTION 11 - TOXICOLOGICAL INFORMATION RTECS#: CAS# 172695-25-9 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
(S)-N-BOC-2-Amino-3-phenylpropyl cyanide - Not listed by ACGIH, IARC, or NTP.
SECTION 12 - ECOLOGICAL INFORMATION
SECTION 13 - DISPOSAL CONSIDERATIONS Dispose of in a manner consistent with federal, state, and local regulations.
SECTION 14 - TRANSPORT INFORMATION IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: III
SECTION 15 - REGULATORY INFORMATION European/International Regulations European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with skin and if swallowed.
Safety Phrases:
S 36/37 Wear suitable protective clothing and gloves. WGK (Water Danger/Protection) CAS# 172695-25-9: No information available. Canada None of the chemicals in this product are listed on the DSL/NDSL list. CAS# 172695-25-9 is not listed on Canada's Ingredient Disclosure List. US FEDERAL TSCA CAS# 172695-25-9 is not listed on the TSCA inventory. It is for research and development use only.
SECTION 16 - ADDITIONAL INFORMATION
MSDS Creation Date: 10/08/2004 Revision #0 Date: Original. The information above is believed to be accurate and represents the best information currently available to us. However, we make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for their particular purposes. In no way shall the company be liable for any claims, losses, or damages of any third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if the company has been advised of the possibility of such damages.

SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Diastereoselective synthesis of a core fragment of ritonavir and lopinavir
    摘要:
    A novel approach to the synthesis of Boc-core, a key starting material for ritonavir and lopinavir involving an unprecedented diastereoselective nitroaldol reaction on beta-amino aldehyde is disclosed. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2011.10.087
  • 作为产物:
    描述:
    N-Boc-L-苯丙氨醇咪唑 、 diphenylphosphinopolystyrene 、 作用下, 以 二氯甲烷 为溶剂, 反应 5.0h, 生成 (S)-N-BOC-2-氨基-3-苯丙氰
    参考文献:
    名称:
    的对映体纯合成Ñ -and Ç -保护的均聚-β氨基酸由α氨基酸的直接同系¶
    摘要:
    对映纯的N和/或C保护的均-β-氨基酸可通过减少羧基官能团和转化所得的N-保护的,容易地且由具有相同侧链的N-保护的α-氨基酸以高收率制备。将β-氨基醇转化为相应的β-氨基碘化物,然后转化为β-氨基氰化物。这种策略的关键步骤是由对映体纯的合成表示Ñ -保护的β-氨基碘化物2和3被平稳地从母体氨基醇得到的1通过聚合物结合的三芳基膦-I 2 在无水二氯甲烷中的络合物。
    DOI:
    10.1016/0040-4020(95)00778-7
点击查看最新优质反应信息

文献信息

  • [EN] 4-ARYL-BUTANE-1,3-DIAMIDES<br/>[FR] 4-ARYL-BUTANE-1,3-DIAMIDES
    申请人:NOVARTIS AG
    公开号:WO2011073316A1
    公开(公告)日:2011-06-23
    The invention relates to compound of the formula (I): in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
    这项发明涉及以下式(I)的化合物:其中取代基如规范中所定义;以自由形式或盐形式存在;其制备方法,其作为药物的用途以及包含它的药物。
  • A Multifaceted Secondary Structure Mimic Based On Piperidine-piperidinones
    作者:Dongyue Xin、Lisa M. Perez、Thomas R. Ioerger、Kevin Burgess
    DOI:10.1002/anie.201400927
    日期:2014.4.1
    that with ideal secondary structures and real interface regions in PPIs. Scaffold 1 presents amino acid side‐chains that are quite separated from each other, in orientations that closely resemble ideal sheet or helical structures, similar non‐ideal structures at PPI interfaces, and regions of other PPI interfaces where the mimic conformation does not resemble any secondary structure. 68 different PPIs
    极简二级结构模拟物通常被制成类似于蛋白质-蛋白质相互作用 (PPI) 中的一个界面,从而扰乱它。我们最近提出合适的化学型可以直接与界面区域匹配,而无需考虑二级结构。在这里,我们描述了新化学型1的模块化合成,其溶液态构象集合的模拟,以及与理想二级结构和 PPI 中真实界面区域的相关性。脚手架1呈现彼此完全分离的氨基酸侧链,其方向与理想的片状或螺旋结构非常相似,在 PPI 界面具有相似的非理想结构,以及其他 PPI 界面的模拟构象与任何二级结构不相似的区域. 68 种不同的 PPI,其中1 个匹配孔的构象被识别。还提出了一种新方法来确定极简模拟晶体结构与其溶液构象的相关性。因此,dld - 1 faf以比最小能量溶液状态高0.91 kcal mol -1的构象结晶。
  • [EN] 4-ARYL-BUTANE-1,3-DIAMIDES<br/>[FR] 4-ARYLBUTANE-1,3-DIAMIDES
    申请人:NOVARTIS AG
    公开号:WO2010086366A1
    公开(公告)日:2010-08-05
    The invention relates to compound of the formula (I) in which the substituents are as defined in the specification; m free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
    这项发明涉及式(I)的化合物,其中取代基如规范中定义;m自由形式或盐形式;其制备,作为药物的用途以及包含它的药物。
  • Entropy-Controlled Catalytic Asymmetric 1,4-Type Friedel-Crafts Reaction of Phenols Using Conformationally Flexible Guanidine/Bisthiourea Organocatalyst
    作者:Yoshihiro Sohtome、Bongki Shin、Natsuko Horitsugi、Rika Takagi、Keiichi Noguchi、Kazuo Nagasawa
    DOI:10.1002/anie.201003172
    日期:——
    Soft and weak cooperation: Conformationally flexible organic compounds were found to promote the title transformation. These “soft” organocatalysts, which are able to control processes through the differential activation entropies (ΔΔS≠S−R) of the reactive intermediates, lead to high stereoselectivities without the requirement of fine‐tuning the reaction temperatures (see scheme).
    软弱合作:构象灵活的有机化合物可促进标题转换。这些“软”有机催化剂,其能够控制通过差动活化熵(ΔΔ过程小号≠小号- - [R )的活性中间体导致高的立体选择性,而不微调反应温度的要求(见方案)。
  • Development of Chiral Organosuperbase Catalysts Consisting of Two Different Organobase Functionalities
    作者:Azusa Kondoh、Masafumi Oishi、Hikaru Tezuka、Masahiro Terada
    DOI:10.1002/anie.202001419
    日期:2020.5.4
    In the field of chiral Brønsted base catalysis, a new generation of chiral catalysts has been highly anticipated to overcome the intrinsic limitation of pronucleophiles that are applicable to the enantioselective reactions. Herein, we reveal conceptually new chiral Brønsted base catalysts consisting of two different organobase functionalities, one of which functions as an organosuperbase and the other
    在手性布朗斯台德碱催化领域中,已经高度期待新一代手性催化剂能够克服可用于对映选择性反应的亲核试剂的固有局限性。本文中,我们从概念上揭示了由两种不同的有机碱官能度组成的新型手性布朗斯台德碱催化剂,其中一种用作有机超强碱,另一种用作底物识别位点。它们的显着活性来自于单个催化剂分子中两个有机碱的独特协同作用,这在酸性较低的亲核试剂α-苯硫基乙酸的前所未有的对映选择性直接曼尼希型反应中得到了证明。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫